Developer docs
API playgroundTry for free, no card

Search company profiles

ELMED Life Sciences

Full company profile

uuid00sttsi

Namestring
ELMED Life Sciences
Legal namestring
ELMED Life Sciences
Company typeenum
Private
Founded yearint
2017
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersHyderabad, India
HQ citystring
Hyderabad
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
probiotic contract manufacturing, microbiome formulations, human health probiotics, animal feed probiotics, aquaculture probiotics
Industry4 codes
1Fermentation Substrates & Sugars (Molasses, Glucose Syrups, Lactose, Malt Extract)
CodeAFAJAJAIPrimaryYes
2Probiotics & Digestive Health Supplements
CodeCRADAGAFPrimaryNo
3Probiotics, Prebiotics & Postbiotics (Direct-Fed Microbials)
CodeAFADALAEPrimaryNo
4Probiotics (Strains, Spore-Formers, Synbiotic Components)
CodeAFAJAKAEPrimaryNo
NAICS code2 codes
  • Food Manufacturing311
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Probiotic Contract Manufacturing
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Contract Manufacturing Services
TypeProfessional Services
Description

Custom probiotic formulation and manufacturing for brands seeking exclusive products. ELMED develops formulations specifically for client brands with IP ownership terms, serving as their manufacturing partner.

elmedlifesciences.com
2Private Label Manufacturing
TypeOne Time License
Description

Supply of existing validated probiotic formulations under client brand names. Faster time-to-market with lower MOQs (typically 500-2,000 units), available across all dosage formats.

elmedlifesciences.com
3Bulk B2B Supply
TypeTransaction Fee
Description

Large-volume probiotic ingredient and finished product supply for private label and custom commercial programs covering all dosage formats with flexible MOQ planning.

elmedlifesciences.com
4R&D and Custom Formulation Services
TypeProfessional Services
Description

Custom strain development, formulation services, and regulatory support for brands requiring proprietary probiotic solutions.

elmedlifesciences.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure
Pricing details3 tiers
1Private Label Manufacturing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Lower MOQs starting at 500-2,000 units; faster time-to-market of 4-8 weeks from artwork sign-off; price varies by dosage format (capsules, sachets, drops, syrups, vials) and volume.

elmedlifesciences.com
2Custom Contract Manufacturing
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Higher MOQs of 5,000+ units; longer lead time of 3-6 months for first batch; pricing reflects custom formulation development and exclusive manufacturing.

elmedlifesciences.com
3Bulk B2B Supply
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Volume-based pricing for large-batch orders; MOQ as per requirement; fully customized packaging and formulation available.

elmedlifesciences.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1ELMED Agrobiotics
Description

A sub-brand focused on agriculture probiotics, operating at elmedagrobiotics.com. Delivers soil and plant probiotics that boost crop yield, nutrient absorption, and support sustainable farming practices.

elmedlifesciences.com
Core offering1 text field

ELMED Life Sciences is a GMP-certified probiotic contract manufacturer that develops, formulates, and produces probiotic, synbiotic, and postbiotic products across human health, animal health, aquaculture, and agriculture segments. It offers private label manufacturing, custom contract manufacturing, bulk B2B supply, and R&D and custom formulation services, exporting clinically validated finished probiotic formulations in capsules, sachets, drops, syrups, oral suspensions, vials, and bulk powder formats to 30+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 40% better survival rates for fish and shrimp farmers
+3 more records
Product overview1 text field

ELMED Life Sciences is a GMP-certified probiotic contract manufacturer offering advanced microbial solutions across four sectors: Human Health, Animal Health, Aquaculture, and Agriculture. The Human Health division provides 25+ probiotic products across multiple delivery formats including oral suspensions (vials) such as Endogermila®, Endogermila® Plus, Sacromed® 5B, Triogermila®, and Triogermila® 10B; drops and syrups including Baby Calm™, Rhambac® GG Drops, and Bacimed® Syrup; capsules such as Rhambac® GG Capsules, Sacromed® Capsules, Ashwagandha Pro, and Shilajit Pro; and sachets including Fitbiotic, MelloFlora, NeoFlora GG, Little One's™, and EasyDigest™. The Animal Health division offers poultry products (ELMAX®, ELSAC®, ELCHICK®) and pet health solutions (MAX360™). The Aquaculture division provides fish and shrimp culture products including ELTOX™, ELGUT™, VIBRICON™, ELMONIA™, and the new AquaVita portfolio (AquaVita SH, AquaVita TL, AquaVita SL). Services include contract manufacturing, R&D and custom formulation, private labeling and co-branding, regulatory and quality support, and global logistics. The company operates GMP-certified facilities in Hyderabad, India and exports to 30+ countries.

Product and service1 record
1Endogermila
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Private, family-owned ingredient manufacturer serving animal feed, human nutrition, and aquaculture. Strong overlap with ELMED's animal-health, aquaculture, and human-health segments, and similar mid-sized contract-manufacturing orientation.

TypeBroad incumbent
Description

Global taste and nutrition company with a probiotics division supplying human-health and functional-food customers. Comparable to ELMED in B2B probiotic supply, though broader in ingredient scope and substantially larger in scale.

TypeEmerging player
Description

Life-sciences supplier of microbial strains and fermentation ingredients. Comparable to ELMED's B2B ingredient-supply side, particularly the cultures and starter-strain offering to other manufacturers.

TypeRegional player
Description

Indian probiotic manufacturer producing Bacillus clausii and Saccharomyces boulardii products for human-health markets. Closest India-based competitor to ELMED's human-health oral-suspension portfolio (e.g., Endogermila, Sacromed).

TypeBroad incumbent
Description

Global leader in microbial biosolutions including human, animal, and plant probiotic cultures. The closest direct competitor to ELMED's contract-manufacturing and strain-supply model, with vastly larger scale but overlapping product categories across all four of ELMED's verticals.

TypeDirect peer
Description

Canadian probiotic and yeast producer serving human nutrition, animal nutrition, and aquaculture markets with proprietary strains. Highly comparable to ELMED's multi-vertical probiotic manufacturing and offers similar Saccharomyces boulardii and Bacillus-based product formats.

TypeEmerging player
Description

US-based agricultural and aquaculture probiotic company offering microbial blends for crop yield and aquaculture water quality. Comparable to ELMED's ELMED Agrobiotics and AquaVita product lines, though concentrated in the Americas rather than Asia.

TypeBroad incumbent
Description

Indian pharmaceutical major with veterinary biologic and probiotic offerings through its Biovet division. Comparable to ELMED in animal-health probiotic manufacturing within the Indian market, though at much larger corporate scale.

TypeBroad incumbent
Description

Global science-based company with a substantial animal-nutrition and gut-health probiotic portfolio including aquaculture solutions. Comparable to ELMED across all four verticals but operates at significantly larger scale and broader ingredient scope.

TypeBroad incumbent
Description

Multinational agribusiness with a direct-fed microbials and aquaculture portfolio. Comparable to ELMED's animal-health and aquaculture divisions, especially in farm-operator customer relationships, but offers far broader feed-ingredient portfolios.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ELMED Life Sciences

Probiotic Contract Manufacturingelmedlifesciences.com

ELMED Life Sciences firmographics

Firmographics
Name
ELMED Life Sciences
Legal name
ELMED Life Sciences
Website
https://elmedlifesciences.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
51–100 employees
Ownership category
akta.pro rank

ELMED Life Sciences industry classification

Industry
Product category
Probiotic Contract Manufacturing
NAICS
Food Manufacturing (311), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro primary industry
Fermentation Substrates & Sugars (Molasses, Glucose Syrups, Lactose, Malt Extract) (AFAJAJAI)
akta.pro secondary industries
Probiotics & Digestive Health Supplements (CRADAGAF), Probiotics, Prebiotics & Postbiotics (Direct-Fed Microbials) (AFADALAE), Probiotics (Strains, Spore-Formers, Synbiotic Components) (AFAJAKAE)

Keywords

  • Probiotic contract manufacturing
  • Microbiome formulations
  • Human health probiotics
  • Animal feed probiotics
  • Aquaculture probiotics

Where ELMED Life Sciences is headquartered

Location

Headquarters

HQ city
Hyderabad
HQ country
India
HQ region
Asia

Offices2 records

Markets served

ELMED Life Sciences business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. Contract Manufacturing Services: Custom probiotic formulation and manufacturing for brands seeking exclusive products. ELMED develops formulations specifically for client brands with IP ownership terms, serving as their manufacturing partner.
  2. Private Label Manufacturing: Supply of existing validated probiotic formulations under client brand names. Faster time-to-market with lower MOQs (typically 500-2,000 units), available across all dosage formats.
  3. Bulk B2B Supply: Large-volume probiotic ingredient and finished product supply for private label and custom commercial programs covering all dosage formats with flexible MOQ planning.
  4. R&D and Custom Formulation Services: Custom strain development, formulation services, and regulatory support for brands requiring proprietary probiotic solutions.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goPrivate Label Manufacturing
One time/ perpetual licenseMulti-year contractCustom Contract Manufacturing
Unit PricingPay-as-you-goBulk B2B Supply

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

ELMED Life Sciences product offering

Product offering

Core offering

ELMED Life Sciences is a GMP-certified probiotic contract manufacturer that develops, formulates, and produces probiotic, synbiotic, and postbiotic products across human health, animal health, aquaculture, and agriculture segments. It offers private label manufacturing, custom contract manufacturing, bulk B2B supply, and R&D and custom formulation services, exporting clinically validated finished probiotic formulations in capsules, sachets, drops, syrups, oral suspensions, vials, and bulk powder formats to 30+ countries.

Product overview

ELMED Life Sciences is a GMP-certified probiotic contract manufacturer offering advanced microbial solutions across four sectors: Human Health, Animal Health, Aquaculture, and Agriculture. The Human Health division provides 25+ probiotic products across multiple delivery formats including oral suspensions (vials) such as Endogermila®, Endogermila® Plus, Sacromed® 5B, Triogermila®, and Triogermila® 10B; drops and syrups including Baby Calm™, Rhambac® GG Drops, and Bacimed® Syrup; capsules such as Rhambac® GG Capsules, Sacromed® Capsules, Ashwagandha Pro, and Shilajit Pro; and sachets including Fitbiotic, MelloFlora, NeoFlora GG, Little One's™, and EasyDigest™. The Animal Health division offers poultry products (ELMAX®, ELSAC®, ELCHICK®) and pet health solutions (MAX360™). The Aquaculture division provides fish and shrimp culture products including ELTOX™, ELGUT™, VIBRICON™, ELMONIA™, and the new AquaVita portfolio (AquaVita SH, AquaVita TL, AquaVita SL). Services include contract manufacturing, R&D and custom formulation, private labeling and co-branding, regulatory and quality support, and global logistics. The company operates GMP-certified facilities in Hyderabad, India and exports to 30+ countries.

Differentiator

Problem solved

Functional benefit

Brands

  • ELMED Agrobiotics: A sub-brand focused on agriculture probiotics, operating at elmedagrobiotics.com. Delivers soil and plant probiotics that boost crop yield, nutrient absorption, and support sustainable farming practices.

Products and services

  • Endogermila

Quantifiable outcome

  • 40% better survival rates for fish and shrimp farmers
  • +3 more outcomes

Companies that use ELMED Life Sciences

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

ELMED Life Sciences technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

ELMED Life Sciences partnerships and signals

Strategic signal

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

ELMED Life Sciences competitors and assessment

Company assessment

Direct peers

  • Kemin Industries: Private, family-owned ingredient manufacturer serving animal feed, human nutrition, and aquaculture. Strong overlap with ELMED's animal-health, aquaculture, and human-health segments, and similar mid-sized contract-manufacturing orientation.
  • Lallemand Bio-Ingredients: Canadian probiotic and yeast producer serving human nutrition, animal nutrition, and aquaculture markets with proprietary strains. Highly comparable to ELMED's multi-vertical probiotic manufacturing and offers similar Saccharomyces boulardii and Bacillus-based product formats.

Broad incumbents

  • Kerry Group (Probiotic Solutions): Global taste and nutrition company with a probiotics division supplying human-health and functional-food customers. Comparable to ELMED in B2B probiotic supply, though broader in ingredient scope and substantially larger in scale.
  • Novonesis (formerly Chr. Hansen): Global leader in microbial biosolutions including human, animal, and plant probiotic cultures. The closest direct competitor to ELMED's contract-manufacturing and strain-supply model, with vastly larger scale but overlapping product categories across all four of ELMED's verticals.
  • Dr. Reddy's Probiotics (Biovet division): Indian pharmaceutical major with veterinary biologic and probiotic offerings through its Biovet division. Comparable to ELMED in animal-health probiotic manufacturing within the Indian market, though at much larger corporate scale.
  • DSM-Firmenich (Animal Nutrition & Health): Global science-based company with a substantial animal-nutrition and gut-health probiotic portfolio including aquaculture solutions. Comparable to ELMED across all four verticals but operates at significantly larger scale and broader ingredient scope.
  • ADM Animal Nutrition & Health: Multinational agribusiness with a direct-fed microbials and aquaculture portfolio. Comparable to ELMED's animal-health and aquaculture divisions, especially in farm-operator customer relationships, but offers far broader feed-ingredient portfolios.

Emerging players

  • Biosynth Carbosynth: Life-sciences supplier of microbial strains and fermentation ingredients. Comparable to ELMED's B2B ingredient-supply side, particularly the cultures and starter-strain offering to other manufacturers.
  • BiOWiSH Technologies: US-based agricultural and aquaculture probiotic company offering microbial blends for crop yield and aquaculture water quality. Comparable to ELMED's ELMED Agrobiotics and AquaVita product lines, though concentrated in the Americas rather than Asia.

Regional players

  • Unique Biotech: Indian probiotic manufacturer producing Bacillus clausii and Saccharomyces boulardii products for human-health markets. Closest India-based competitor to ELMED's human-health oral-suspension portfolio (e.g., Endogermila, Sacromed).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

ELMED Life Sciences social profiles

Digital presence

ELMED Life Sciences compliance and trust

Trust signal

Compliance4 records

ELMED Life Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ELMED Life Sciences leadership team

Management profile

Number of profiles

ELMED Life Sciences funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ELMED Life Sciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ELMED Life Sciences

What does ELMED Life Sciences do?

ELMED Life Sciences is a GMP-certified probiotic contract manufacturer that develops, formulates, and produces probiotic, synbiotic, and postbiotic products across human health, animal health, aquaculture, and agriculture segments. It offers private label manufacturing, custom contract manufacturing, bulk B2B supply, and R&D and custom formulation services, exporting clinically validated finished probiotic formulations in capsules, sachets, drops, syrups, oral suspensions, vials, and bulk powder formats to 30+ countries.

Is ELMED Life Sciences a public or private company?

ELMED Life Sciences is a private company. It is classified as venture growth investor backed and is currently operating.

When was ELMED Life Sciences founded?

ELMED Life Sciences was founded in 2017. It employs 51 to 100 people.

Where is ELMED Life Sciences based?

ELMED Life Sciences is headquartered in Hyderabad, India, in the Asia region.

How does ELMED Life Sciences make money?

Four revenue lines are on record. Contract Manufacturing Services are the primary driver. The others are private Label Manufacturing, bulk B2B Supply and R&D and Custom Formulation Services.

Who are ELMED Life Sciences's main competitors?

Direct peers on record are Kemin Industries and Lallemand Bio-Ingredients. Broad incumbents are Kerry Group (Probiotic Solutions), Novonesis (formerly Chr. Hansen), Dr. Reddy's Probiotics (Biovet division), DSM-Firmenich (Animal Nutrition & Health) and ADM Animal Nutrition & Health. Emerging players are Biosynth Carbosynth and BiOWiSH Technologies. Unique Biotech is listed as a regional player.

Does ELMED Life Sciences have an API?

No public API is recorded for ELMED Life Sciences.

What industry is ELMED Life Sciences in?

ELMED Life Sciences's product category is Probiotic Contract Manufacturing. Its primary akta.pro industry code is AFAJAJAI, Fermentation Substrates & Sugars (Molasses, Glucose Syrups, Lactose, Malt Extract), with a secondary code of CRADAGAF, Probiotics & Digestive Health Supplements. Its NAICS code is 311 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Indian Startup TimesELMED Life Sciences Raises $2.7 Million in Series A Funding from AgriSURE Fund (NABVENTURES)ELMED Life Sciences raised $2.7 million in Series A funding from AgriSURE Fund, managed by NABVENTURES, to expand its manufacturing, R&D, and international market presence. The company specializes in probiotic and biological solutions across animal health, agriculture, aquaculture, and human health, responding to a global shift towards sustainable farming practices.BusinessLineELMED Life Sciences raises $2.7 millionELMED Life Sciences, a probiotic and biological solutions provider, has raised $2.7 million (₹25 crore) in Series A funding from AgriSURE Fund, managed by NABVENTURES (the venture capital arm of NABARD). The investment will support expansion of manufacturing capabilities in Hyderabad, strengthen R&D in microbiome-based solutions, and scale distribution across tier 2 and tier 3 markets in India along with international markets. The company focuses on probiotic-based solutions for animal health, agriculture, aquaculture, and human health sectors.https://www.outlookbusiness.com/ELMED Bags $2.7MnFunding to Scale Biotech Solutions in Agriculture, Health – Outlook BusinessELMED Life Sciences has raised $2.7 million in Series A funding from NABVENTURES, the venture capital arm of NABARD, through its AgriSURE Fund. The Hyderabad-based biotech company develops probiotic and biological solutions across animal health, agriculture, aquaculture, and human health, and will use the proceeds to expand manufacturing capacity, strengthen R&D, and scale distribution in domestic and international markets. The company currently exports to more than 18 countries and aims to deepen its reach in Tier 2 and Tier 3 Indian markets while expanding into Europe, Asia, and Latin America.The Times of IndiaElmed Life Sciences raises $2.7 million from Nabard-backed Agrisure FundHyderabad-based Elmed Life Sciences has raised $2.7 million from Agrisure Fund, which is managed by Nabard-backed Nabventures, to expand its probiotic and biological solutions business. The funding will be used to increase production capabilities, strengthen microbiome-based research and development, and extend distribution across key markets. The company, which operates as a B2B firm serving clients like Aurobindo and Apex Laboratories, exports to more than 18 countries and plans to expand into Europe, Asia, and Latin America.India's most comprehensive portal on pharmaceutical NewsELMED Life Sciences raises $2.7 mn in Series A funding from AgriSURE Fund managed by NABVENTURESELMED Life Sciences raised $2.7 million in Series A funding from AgriSURE Fund, managed by NABVENTURES. The investment will support manufacturing expansion in Hyderabad, R&D in microbiome-based solutions, and distribution scaling across Tier 2 and 3 markets and international growth.IndiaWeb2ELMED Life Sciences Raises $2.7 Million in Series A Funding from AgriSURE Fund (NABVENTURES)ELMED Life Sciences has raised $2.7 million in Series A funding from AgriSURE Fund, the agri-focused investment fund managed by NABVENTURES. The company, which develops probiotic and biological solutions for animal health, agriculture, aquaculture, and human health, will use the funding to expand manufacturing capabilities in Hyderabad, strengthen R&D in microbiome-based solutions, and scale distribution across Tier 2 and Tier 3 markets in India while building international presence. ELMED, the first company in India to develop probiotics specifically for agriculture, currently exports to over 18 countries.EntrackrELMED Life Sciences raises $2.7 Mn in Series A from NABVENTURESELMED Life Sciences, a biotech startup specializing in probiotic and biological solutions for animal health, agriculture, aquaculture, and human health, has raised $2.7 million (approximately Rs 25 crore) in a Series A funding round from AgriSURE Fund, managed by NABVENTURES. The funds will be used to expand manufacturing capacity, strengthen research and development, and scale distribution across domestic and international markets. The company, which currently exports to over 18 countries and operates a B2B model, plans to expand its Hyderabad-based manufacturing operations and deepen its presence in tier 2 and tier 3 markets.BwdisruptElmed Life Sciences Raises $2.7 Mn From Nabard-backed Agrisure FundElmed Life Sciences has raised USD 2.7 million in a funding round from Nabard-backed Agrisure Fund to scale its operations in the life sciences and agri-biotech space. The company will use the capital to strengthen research and development, enhance manufacturing capabilities, and expand its market presence, focusing on sustainable and science-driven solutions for agriculture and allied sectors. The investment reflects growing investor interest in agri-biotech ventures aligned with long-term environmental and agricultural goals.VCCircleElmed Life Sciences, Qweebi raise early-stage capital; A91 bets on Deccan AIThree Indian startups secured early-stage funding: Elmed Life Sciences raised $2.7 million in Series A funding from AgriSURE Fund (Nabventures/NABARD) to expand manufacturing and R&D for probiotic solutions in animal health, agriculture, aquaculture and human health; Qweebi, a K-12 online STEM platform, raised $500,000 in a seed round led by Inflection Point Ventures with participation from Jeroen Tas and Arpit Jain; and Deccan AI, a data company serving AI labs and enterprises, raised $25 million in a Series A round led by A91 Partners with participation from Susquehanna VC and Prosus Ventures. Additionally, Moving Tech Innovations (parent company of Namma Yatri) acquired Netherlands-based Automicle Holding BV to expand its zero-commission open mobility model globally.